Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib | |
Ren, Xiaomei ; Pan, Xiaofen ; Zhang, Zhang ; Wang, Deping ; Lu, Xiaoyun ; Li, Yupeng ; Wen, Donghai ; Long, Huoyou ; Luo, Jinfeng ; Feng, Yubing ; Zhuang, Xiaoxi ; Zhang, Fengxiang ; Liu, Jianqi ; Leng, Fang ; Lang, Xingfen ; Bai, Yang ; She, Miaoqin ; Tu, Zhengchao ; Pan, Jingxuan ; Ding, Ke | |
刊名 | JOURNAL OF MEDICINAL CHEMISTRY
![]() |
2013 | |
卷号 | 56期号:3 |
ISSN号 | 0022-2623 |
学科主题 | Pharmacology & Pharmacy |
语种 | 英语 |
公开日期 | 2016-12-16 |
内容类型 | 期刊论文 |
源URL | [http://ir.gibh.ac.cn/handle/344009/764] ![]() |
专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
推荐引用方式 GB/T 7714 | Ren, Xiaomei,Pan, Xiaofen,Zhang, Zhang,et al. Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib[J]. JOURNAL OF MEDICINAL CHEMISTRY,2013,56(3). |
APA | Ren, Xiaomei.,Pan, Xiaofen.,Zhang, Zhang.,Wang, Deping.,Lu, Xiaoyun.,...&Ding, Ke.(2013).Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib.JOURNAL OF MEDICINAL CHEMISTRY,56(3). |
MLA | Ren, Xiaomei,et al."Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib".JOURNAL OF MEDICINAL CHEMISTRY 56.3(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论